Figure 2.

Risk strata distribution using REVEAL Lite 2 versus clinician assessment in total study population (N = 299). (a) The majority of patients were categorized as intermediate risk by clinician assessment. The majority of patients were categorized as high risk by REVEAL Lite 2. (b, c) Red shaded lines and boxes show patients whose risk level was underestimated by clinicians, relative to that calculated by REVEAL Lite 2. Risk was underestimated most commonly in clinician‐assessed intermediate patients. (d) Most risk assessments between clinician gestalt and REVEAL Lite 2 were incongruent at baseline (54.1%). Numbers may not add to 100% due to rounding.